US FDA clears Abbott's continuous glucose monitors for over-the-counter use

June 10 (Reuters) - Abbott said on Monday that the U.S. Food and Drug Administration has cleared its two continuous glucose monitoring systems for over-the-counter use. (Reporting by Sriparna Roy in Bengaluru; Editing by Shailesh Kuber)